Involution von Cherubismus im MRT unter Therapie mit Imatinib

Rofo. 2017 Jul;189(7):675-677. doi: 10.1055/s-0043-105074. Epub 2017 Apr 26.

[Article in German]

Authors

Sebastian Eiden¹, Ekkehart Lausch², Stephan Meckel¹

Affiliations

¹ Dept. of Neuroradiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
² Dept. of Pediatric Genetics, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

PMID: 28445911
DOI: 10.1055/s-0043-105074

No abstract available

Publication types

Case Reports

MeSH terms

Cherubism / diagnostic imaging*
Cherubism / drug therapy*
Child, Preschool
Diagnosis, Differential
Drug Monitoring / methods*
Humans
Imatinib Mesylate / administration & dosage*
Magnetic Resonance Imaging / methods*
Male
Protein Kinase Inhibitors / administration & dosage
Treatment Outcome

Substances

Protein Kinase Inhibitors
Imatinib Mesylate